Abstract

In the microscopic realm of pharmacology, we are witnessing a revolutionary era marked by the rapid evolution of nanopharmaceutics - a field converging the intricacies of nanotechnology with drug development. Emerging as a veritable force in the war against infectious diseases, nanopharmaceutics, coupled with antimicrobial applications, is pushing the boundaries of our fight against bacterial and viral pathogens. Drawing upon my experience in nanobioengineering, I'm excited to delve into recent advancements in this domain, demonstrating the promise nanopharmaceutics holds as we encounter an unprecedented escalation of antimicrobial resistance worldwide.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.